Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertension: HELP
Shivaani Kummar
Based on 2 articles published since 2008
||||
Expertise Level

  What is this?

With only 2 published articles on Hypertension from 2008 through 2019, it is not possible for Expertscape to reliably rate Shivaani Kummar's expertise on this topic.

Uncounted papers?
Work Locations
Details
Most likely:    National Institutes of Health      
2013
  • National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 23630200
2010
  • Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA. · Pubmed 20630084
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Shivaani Kummar in 2008-2019 about Hypertension:

  • Cediranib for metastatic alveolar soft part sarcoma. 2013
  • Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. 2010
Show List of Full Article Records
Google Searches

Learn more about Shivaani Kummar using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Institutes of Health
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Institutes of Health
2013
  • National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. · Pubmed 23630200
2010
  • Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA. · Pubmed 20630084
Yearly article counts 000000100100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.